These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 28542740
21. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study. Makler A, Asghar W. Int J Mol Sci; 2023 Mar 07; 24(6):. PubMed ID: 36982154 [Abstract] [Full Text] [Related]
23. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Zhang J, Zhao CY, Zhang SH, Yu DH, Chen Y, Liu QH, Shi M, Ni CR, Zhu MH. Oncol Rep; 2014 Mar 07; 31(3):1157-64. PubMed ID: 24398877 [Abstract] [Full Text] [Related]
24. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma. Meijer LL, Garajová I, Caparello C, Le Large TYS, Frampton AE, Vasile E, Funel N, Kazemier G, Giovannetti E. Ann Surg; 2020 Jun 07; 271(6):1137-1147. PubMed ID: 30394883 [Abstract] [Full Text] [Related]
31. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study. Jiang D, Yuan X, Ni J, Shen L, Cai M, Xu L. Can J Gastroenterol Hepatol; 2021 Oct 07; 2021():8882129. PubMed ID: 34222137 [Abstract] [Full Text] [Related]
32. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients. Kawamura S, Iinuma H, Wada K, Takahashi K, Minezaki S, Kainuma M, Shibuya M, Miura F, Sano K. J Hepatobiliary Pancreat Sci; 2019 Feb 07; 26(2):63-72. PubMed ID: 30561106 [Abstract] [Full Text] [Related]
36. A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study. Seeger N, Gutknecht S, Zschokke I, Fleischmann I, Roth N, Metzger J, Weber M, Breitenstein S, Grochola LF. JMIR Res Protoc; 2024 May 13; 13():e54042. PubMed ID: 38635586 [Abstract] [Full Text] [Related]
37. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM. World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360 [Abstract] [Full Text] [Related]